Steven Cohen's TMCI Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 169,792 shares of Treace Medical Concepts, Inc. (TMCI) worth $415,990, representing 0.00% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in TMCI, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 1.07 M shares. Largest reduction occurred in Q4 2023, reducing 1.25 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Treace Medical Concepts (TMCI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Treace Medical Concepts (TMCI) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +169,792 | New Buy | 169,792 | $2.45 |
| Q1 2025 | -190,100 | Sold Out | 0 | $0.00 |
| Q4 2024 | +190,100 | New Buy | 190,100 | $7.44 |
| Q3 2024 | -362,710 | Sold Out | 0 | $0.00 |
| Q2 2024 | +362,710 | New Buy | 362,710 | $6.65 |
| Q4 2023 | -1.25 M | Sold Out | 0 | $0.00 |
| Q3 2023 | -165,916 | Reduce 11.70% | 1.25 M | $13.11 |
| Q2 2023 | +1.07 M | Add 302.36% | 1.42 M | $25.58 |
| Q1 2023 | -43,154 | Reduce 10.91% | 352,552 | $25.19 |
| Q4 2022 | +100,275 | Add 33.94% | 395,706 | $22.99 |
| Q3 2022 | +75,236 | Add 34.17% | 295,431 | $22.07 |
| Q2 2022 | +8,435 | Add 3.98% | 220,195 | $14.34 |
| Q1 2022 | +177,410 | Add 516.48% | 211,760 | $18.91 |
| Q4 2021 | +34,350 | New Buy | 34,350 | $18.63 |
Steven Cohen's Treace Medical Concepts Investment FAQs
Steven Cohen first purchased Treace Medical Concepts, Inc. (TMCI) in Q4 2021, acquiring 34,350 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Treace Medical Concepts, Inc. (TMCI) for 14 quarters since Q4 2021.
Steven Cohen's largest addition to Treace Medical Concepts, Inc. (TMCI) was in Q2 2023, adding 1,418,544 shares worth $36.29 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 169,792 shares of Treace Medical Concepts, Inc. (TMCI), valued at approximately $415,990.
As of the Q4 2025 filing, Treace Medical Concepts, Inc. (TMCI) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Treace Medical Concepts, Inc. (TMCI) was 1,418,544 shares, as reported at the end of Q2 2023.